ACF Equity Research reposted this
Combination therapies in oncology are a big deal. GeoVax Labs, Inc.'s Gedeptin is preparing for a Phase II study along with a checkpoint inhibitor for head & neck cancer. Join Unboxing Biotech & David A. Dodd where we introduce the 36 subject trial. $GOVX https://lnkd.in/g3BPF3bB
